From Ganfyd

Jump to: navigation, search
Favipiravir was first developed as a selective inhibitor of influenza RNA-dependent RNA polymerase[1]. Its active form is favipiravir-ribofuranosyl-5'-triphosphate (RTP) and this can inhibit several viral RNA polymerases but others are resistant to its action. Sensitive viruses include arenaviruses, phleboviruses such as those causing Rift Valley fever, sandfly fever and Punta Toro, hantaviruses, flaviviruses such as those causing yellow fever and West Nile fever), Western equine encephalitis virus, respiratory syncytial virus, norovirus, polio virus and even Ebola virus[2].